共 491 条
[91]
Price K(2014)Role of somatostatin receptor-2 in gentamicin-induced auditory hair cell loss in the mammalian inner ear PLoS One 9 308-undefined
[92]
Zhu X(2018)The bone remodelling cycle Ann Clin Biochem 55 2033-undefined
[93]
Guimaraes P(2002)Growth hormone and low dose estrogen in turner syndrome: results of a United States multi-center trial to near-final height J Clin Endocrinol Metab 87 23-undefined
[94]
Vasilyeva O(2010)Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with Turner syndrome Horm Res Paediatr 74 891-undefined
[95]
Frisina R(1988)Stabilization of hearing loss in Paget’s disease with calcitonin and etidronate Arch Otolaryngol Head Neck Surg 114 267-undefined
[96]
Horner K(2016)Treatment for progressive hearing loss due to Paget’s disease of bone – a case report and literature review J Int Adv Otol. 11 169-undefined
[97]
Cazals Y(2003)Posible beneficio de la calcitonina en el tratamiento de la otosclerosis Acta Otorrinolaringol Esp 54 1295-undefined
[98]
Guieu R(2008)Meniere’s attacks occur in the inner ear with excessive vasopressin type-2 receptors J Neuroendocrinol 20 901-undefined
[99]
Lenoir M(2007)The relevance of an elevation in the plasma vasopressin levels to the pathogenesis of Meniere’s attack J Neuroendocrinol 19 613-undefined
[100]
Sauze N(2011)Vasopressin in definite Meniere’s disease with positive electrocochleographic findings Acta Otolaryngol 131 161-undefined